Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

<p>Abstract</p> <p>Background</p> <p>Despite all benefit provided by established therapies prognosis of gastric cancer remains poor. Targeted inhibition of platelet derived growth factor receptor (PDGFR) by imatinib may influence tumor growth and amplify chemotherapeuti...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mayr Martina, Becker Karen, Schulte Nadine, Belle Sebastian, Hofheinz Ralf, Krause Annekatrin, Schmid Roland M, Röcken Christoph, Ebert Matthias P
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2012-12-01
Edice:BMC Cancer
Témata:
Imatinib
PDGF
Gastric cancer
Chemotherapy
On-line přístup:http://www.biomedcentral.com/1471-2407/12/587
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky